Ga-citrate | Gelatin capsules | To study the gastrointestinal transit time | Extended release | Wagner et al. (2017) |
Tributyrin | Whey protein and γ-cyclodextrin | To study In vitro release of butyric acid for the treatment of intestinal disorder | Controlled release | Donovan et al. (2017) |
Sulforhodamine 101 (fluorescent probe as model drug) | Rhamnogalacturonan-I | For the treatment of colonic cancer and better protection of the drug throughout the GIT | Controlled release | Svagan et al. (2016) |
Ivermectin | PCL elastomers | For extended release of anti-malaria drugs | Controlled and extended release | Bellinger et al. (2016) |
Veledimex | Gelatin capsules | To regulate gene expression and studying the drug pharmacokinetics | Controlled release | Mulugeta et al. (2018) |
Paracetamol | Sporopollenin exine capsules (SEC) with carboxymethyl cellulose and epichlorohydrin coating | To enhance bioavailability of paracetamol | Extended release | Alshehri et al. (2016) |
Curcumin | Mesoporous silica microcapsules using N-hexadecyl palmitate (NHP) in Tween 40 | To improve the stability and gastro-resistant delivery intestinal absorption of curcumin | Controlled release | Kim et al. (2016) |
Probucol | Chenodeoxycholic acid (CDCA) microcapsules | To improve permeation properties of the drug | Targeted oral delivery | Mooranian et al. (2015) |
Gliclazide | CDCA and sodium alginate | To enhance delivery of Gliclazide with CDCA in lower intestine with prolong release | Targeted oral delivery | Mathavan et al. (2016) |
Fluorescent particles | Particle-in-particle | For effective colon cancer treatment | Targeted oral delivery | Ma et al. (2015) |
Sodium salt of Furosemide | Microwells of poly-l-lactic acid with coating of Eudragit | To deliver the powdered drug to the target site throughout the GIT | Targeted oral delivery | Nielsen et al. (2015) |
Insulin | Whey protein (WPI), polyglycerol and sodium alginate (SA) or carboxymethylcellulose (CMC) coating | To enhance oral drug delivery | Controlled release | Cardenas-Bailon et al. (2015) |
Insulin | (PLGA)-lipid –PEG hybrid nanoparticles filled in gelatin capsules with hydro-proxy-propyl methyl cellulose phthalate polymer coating | To enhance bioavailability and protection against acidic environment | Controlled release | Yu et al. (2015) |
Oxycodone | DETERx microsphere capsules | To enhance the bioavailability specially for patients with dysphagia | Controlled and extended release | Fleming et al. (2016) |
Budesonide | Eudragit S-100 and L-100 gelatin capsules | To increase the lag time to target colon related diseases | Controlled release | Yehia et al. (2011) |
Docetaxel | Surfactant based solid dispersions in gelatin capsule | To attain higher solubility and dissolution | Controlled release | Moes et al. (2011) |